To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HS1BP3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
176 supporting clones for gene HS1BP3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_022460.3   HS1BP3.a -10 to 2392 1 to 2403 exact RefSeq,   2403/2403
(100 %)
0 diff
(100 %id)
AL541026 placenta HS1BP3.a -9 to 942 3 to 950       948/950
(99 %)
19 diff
(98.0 %id)
AK314383 uterus HS1BP3.a 1 to 1209 8 to 1216 V260M tiling clone,   1216/1216
(100 %)
2 diff
(99.9 %id)
BQ427488 melanotic melanoma, skin HS1BP3.a 1 to 641 8 to 652       652/759
(85 %)
11 diff
(98.6 %id)
DB258840 uterus HS1BP3.a 1 to 557 8 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA021218   HS1BP3.a 1 to 561 5 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DA716206   HS1BP3.a 1 to 478 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
BI758474 brain HS1BP3.a 5 to 872 1 to 866       866/868
(99 %)
17 diff
(98.1 %id)
TI_57215421   HS1BP3.a 5 to 872 1 to 866       866/868
(99 %)
17 diff
(98.1 %id)
CR596701 Placenta Cot 25-normalized HS1BP3.a 6 to 2344 1 to 2339 exact tiling clone,   2339/2339
(100 %)
0 diff
(100 %id)
AL525113 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized HS1BP3.a 6 to 836 1 to 830       830/830
(100 %)
9 diff
(99.0 %id)
BX399617 Placenta Cot 25-normalized HS1BP3.a 6 to 950 1 to 942       942/1038
(90 %)
17 diff
(98.4 %id)
BC050636 Brain, adult, 6 pooled whole brains HS1BP3.a 10 to 2372 1 to 2363 V260M A388T available from MGC, AAA   2363/2363
(100 %)
5 diff
(99.8 %id)
CN310015 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells HS1BP3.a 10 to 219 1 to 210       210/210
(100 %)
2 diff
(99.1 %id)
CT000017 T-Lymphocytes HS1BP3.a 10 to 578 1 to 570       570/572
(99 %)
3 diff
(99.5 %id)
BE616909 adenocarcinoma, Pancreas HS1BP3.a 24 to 613 47 to 704       501/704
(71 %)
36 diff
(94.9 %id)
BE614988 adenocarcinoma, Pancreas HS1BP3.a 30 to 803 1 to 763       763/919
(83 %)
17 diff
(98.2 %id)
TI_1948211275   HS1BP3.a 30 to 509 138 to 617       480/508
(94 %)
6 diff
(98.9 %id)
TI_1948211561   HS1BP3.a 30 to 485 138 to 593       456/484
(94 %)
6 diff
(98.8 %id)
TI_1948211833   HS1BP3.a 30 to 509 138 to 617       480/508
(94 %)
6 diff
(98.9 %id)
CV029540 mixed HS1BP3.a 31 to 655 1 to 625       625/625
(100 %)
0 diff
(100 %id)
EL734629 mixed HS1BP3.a 31 to 652 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
EL734681 mixed HS1BP3.a 31 to 645 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BE614835 adenocarcinoma, Pancreas HS1BP3.a 31 to 814 1 to 788       788/964
(81 %)
17 diff
(98.3 %id)
BE615684 adenocarcinoma, Pancreas HS1BP3.a 34 to 594 1 to 574       574/717
(80 %)
31 diff
(95.7 %id)
DA310822 hippocampus HS1BP3.a 36 to 604 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BE252671 eye, retinoblastoma HS1BP3.a 51 to 707 1 to 653       653/711
(91 %)
9 diff
(98.8 %id)
CR997437 T-Lymphocytes HS1BP3.a 60 to 812 1 to 753       753/773
(97 %)
1 diff
(99.9 %id)
BX354596 Neuroblastoma Cot 25-normalized HS1BP3.a 63 to 911 105 to 945       929/974
(95 %)
19 diff
(98.1 %id)
DA741611   HS1BP3.a 63 to 493 77 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
BF871798 lung_tumor HS1BP3.a 90 to 409 1 to 320       320/320
(100 %)
1 diff
(99.7 %id)
CN310016 embryonic stem cells, cell lines H1, H7, andH9 HS1BP3.a 102 to 800 12 to 710       699/710
(98 %)
9 diff
(98.8 %id)
BQ323499 colon_ins HS1BP3.a 118 to 494 1 to 383       383/384
(99 %)
20 diff
(94.8 %id)
BE868102 adenocarcinoma, colon HS1BP3.a 531 to 1014 1 to 484       484/486
(99 %)
7 diff
(98.6 %id)
BQ073210 epidermoid carcinoma, cell line, lung HS1BP3.a 565 to 1384 1 to 833       833/1000
(83 %)
18 diff
(98.2 %id)
BQ884418 eye, normal pigmented retinal epithelium HS1BP3.a 577 to 1252 1 to 684       684/897
(76 %)
17 diff
(98.2 %id)
BI049923 placenta_normal HS1BP3.a 585 to 1052 474 to 2       473/475
(99 %)
36 diff
(92.5 %id)
BI256646 cervical carcinoma cell line, cervix HS1BP3.a 601 to 1199 1 to 599       599/599
(100 %)
4 diff
(99.4 %id)
BG753647 eye, normal pigmented retinal epithelium HS1BP3.a 603 to 1404 1 to 807       807/807
(100 %)
26 diff
(96.8 %id)
BX371952 Placenta Cot 25-normalized HS1BP3.a 607 to 1501 890 to 1       890/890
(100 %)
13 diff
(98.6 %id)
BI084236 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 669 to 1477 1 to 814   fully sequenced,   814/814
(100 %)
28 diff
(96.6 %id)
BI084243 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 669 to 1374 1 to 706       706/709
(99 %)
16 diff
(97.8 %id)
BU158263 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 669 to 1557 30 to 921       892/921
(96 %)
20 diff
(97.9 %id)
BQ670863 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 669 to 1470 15 to 817       803/962
(83 %)
17 diff
(98.3 %id)
BQ675596 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 669 to 1469 11 to 812       802/967
(82 %)
21 diff
(97.9 %id)
BU173754 melanotic melanoma, cell line, skin HS1BP3.a 671 to 1389 1 to 723       723/880
(82 %)
25 diff
(97.2 %id)
BU184916 melanotic melanoma, cell line, skin HS1BP3.a 671 to 1478 1 to 809       809/883
(91 %)
20 diff
(97.8 %id)
BU196128 melanotic melanoma, cell line, skin HS1BP3.a 671 to 1469 1 to 800       800/878
(91 %)
31 diff
(96.5 %id)
BU184935 melanotic melanoma, cell line, skin HS1BP3.a 671 to 1536 1 to 870       870/888
(97 %)
25 diff
(97.2 %id)
BQ669025 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 671 to 1483 1 to 822       822/905
(90 %)
33 diff
(96.4 %id)
BQ674472 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 671 to 1395 1 to 729       729/983
(74 %)
15 diff
(98.5 %id)
BQ674057 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 671 to 1490 1 to 824       824/951
(86 %)
15 diff
(98.5 %id)
BQ675285 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 671 to 1536 1 to 869       869/951
(91 %)
32 diff
(96.7 %id)
DB505018 hypothalamus HS1BP3.a 691 to 1173 1 to 484       484/484
(100 %)
8 diff
(98.4 %id)
BG763763 melanotic melanoma, high MDR (cell line), skin HS1BP3.a 815 to 1318 16 to 519       508/521
(97 %)
16 diff
(97.0 %id)
BG255219 adenocarcinoma, cell line, Prostate HS1BP3.a 979 to 1741 1 to 752       752/1053
(71 %)
30 diff
(97.2 %id)
BF526263 brain, glioblastoma with EGFR amplification HS1BP3.a 1080 to 1833 1 to 739       739/740
(99 %)
37 diff
(95.0 %id)
BQ269364 Pancreas, Purified pancreatic islet HS1BP3.a 1212 to 1698 1 to 489       489/489
(100 %)
12 diff
(97.6 %id)
CK825736 Pancreas, Purified pancreatic islet HS1BP3.a 1233 to 1804 1 to 572     Submitted on the opposite strand 572/572
(100 %)
9 diff
(98.5 %id)
CN310011 embryonic stem cells, cell lines H1, H7, andH9 HS1BP3.a 1261 to 1936 7 to 683       677/683
(99 %)
6 diff
(99.2 %id)
BU186041 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 2017 1 to 764       764/1002
(76 %)
18 diff
(98.3 %id)
BQ675051 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 2116 1 to 875       875/968
(90 %)
38 diff
(96.1 %id)
BQ674060 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 2101 1 to 856       856/971
(88 %)
41 diff
(95.8 %id)
BQ674065 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 1978 1 to 721       721/870
(82 %)
29 diff
(96.7 %id)
BQ673411 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 2060 1 to 818       818/930
(87 %)
36 diff
(96.2 %id)
BQ675292 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1262 to 2112 1 to 869       869/951
(91 %)
41 diff
(95.7 %id)
AL541025 placenta HS1BP3.a 1294 to 2323 1034 to 1       1034/1039
(99 %)
55 diff
(94.8 %id)
BX399616 Placenta Cot 25-normalized HS1BP3.a 1294 to 2333 1032 to 12       1021/1066
(95 %)
0 diff
(100 %id)
BI084738 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1413 to 2345 942 to 9       934/972
(96 %)
0 diff
(100 %id)
BQ356141 head_neck HS1BP3.a 1470 to 1677 1 to 209       209/209
(100 %)
9 diff
(95.7 %id)
BI084731 epidermoid carcinoma, cell line, salivary gland HS1BP3.a 1472 to 2324 876 to 1   fully sequenced,   876/876
(100 %)
57 diff
(93.5 %id)
TI_154130802   HS1BP3.a 1482 to 2372 969 to 84   AAA   886/940
(94 %)
24 diff
(97.5 %id)
AL525112 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized HS1BP3.a 1488 to 2357 872 to 1       872/872
(100 %)
42 diff
(95.2 %id)
BM423409 amelanotic melanoma, cell line, skin HS1BP3.a 1495 to 2378 1 to 885       885/1042
(84 %)
30 diff
(97.2 %id)
BE734660 choriocarcinoma, placenta HS1BP3.a 1496 to 2372 30 to 903   AAA   874/903
(96 %)
6 diff
(99.4 %id)
BQ645631 hepatocellular carcinoma, cell line, Liver HS1BP3.a 1499 to 2166 1 to 674       674/922
(73 %)
29 diff
(96.9 %id)
BQ653994 hepatocellular carcinoma, cell line, Liver HS1BP3.a 1499 to 2337 22 to 869       848/993
(85 %)
35 diff
(96.5 %id)
TI_227714244   HS1BP3.a 1503 to 2372 948 to 91   AAA   858/988
(86 %)
26 diff
(97.4 %id)
CN481920 eye HS1BP3.a 1508 to 2086 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
BG477335 melanotic melanoma, skin HS1BP3.a 1511 to 2046 1 to 538       538/762
(70 %)
9 diff
(98.9 %id)
CN310014 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 HS1BP3.a 1568 to 1981 1 to 414       414/414
(100 %)
3 diff
(99.3 %id)
BX329645 Neuroblastoma Cot 25-normalized HS1BP3.a 1600 to 2338 734 to 1       734/897
(81 %)
31 diff
(96.6 %id)
TI_149287876   HS1BP3.a 1676 to 2372 779 to 85   AAA   695/1015
(68 %)
16 diff
(98.5 %id)
CA419233 Chondrosarcoma Grade II, Left Pelvis HS1BP3.a 1689 to 2372 701 to 19   AAA   683/683
(100 %)
6 diff
(99.2 %id)
BQ773417 Chondrosarcoma Cell line HS1BP3.a 1693 to 2388 712 to 19   AAA   694/697
(99 %)
3 diff
(99.6 %id)
CD364958 Alveolar Macrophage, lung HS1BP3.a 1693 to 2372 696 to 19   AAA   678/679
(99 %)
5 diff
(99.3 %id)
TI_154127679   HS1BP3.a 1705 to 2372 774 to 109   AAA   666/961
(69 %)
6 diff
(99.4 %id)
BU623819 cell lines, Enchondroma HS1BP3.a 1707 to 2372 684 to 19   AAA   666/666
(100 %)
4 diff
(99.4 %id)
BG911862 anaplastic oligodendroglioma with 1p/19qloss, brain HS1BP3.a 1711 to 2380 1 to 670       670/687
(97 %)
15 diff
(97.9 %id)
CA417312 Chondrosarcoma Cell line HS1BP3.a 1714 to 2372 675 to 19   AAA   657/657
(100 %)
6 diff
(99.1 %id)
BG911499 anaplastic oligodendroglioma with 1p/19qloss, brain HS1BP3.a 1733 to 2353 1 to 618       618/671
(92 %)
11 diff
(98.4 %id)
BM970057 lung HS1BP3.a 1783 to 2372 607 to 19   AAA   589/589
(100 %)
3 diff
(99.5 %id)
BI770484 pooled lung and spleen HS1BP3.a 1785 to 2326 1 to 569       569/779
(73 %)
70 diff
(91.1 %id)
TI_57179754   HS1BP3.a 1787 to 2326 30 to 596       567/806
(70 %)
6 diff
(99.3 %id)
BF841292 head_neck HS1BP3.a 1800 to 2231 436 to 6     Submitted on the opposite strand 431/436
(98 %)
0 diff
(100 %id)
BX094207 multiple sclerosis lesions HS1BP3.a 1809 to 1984 1 to 178       178/178
(100 %)
2 diff
(98.9 %id)
N32385 melanocyte HS1BP3.a 1820 to 1968 1 to 150       150/150
(100 %)
1 diff
(99.4 %id)
CN310013 embryonic stem cells, DMSO-treated H9 cellline HS1BP3.a 1835 to 2191 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
AA534876 colon HS1BP3.a 1862 to 2374 513 to 1       513/513
(100 %)
11 diff
(97.9 %id)
BF340358 brain, glioblastoma with EGFR amplification HS1BP3.a 1866 to 2372 1 to 507   AAA   507/507
(100 %)
0 diff
(100 %id)
DB576288 hypothalamus HS1BP3.a 1886 to 2370 1 to 485     Submitted on the opposite strand 485/487
(99 %)
9 diff
(98.2 %id)
AI498495 anaplastic oligodendroglioma, brain HS1BP3.a 1907 to 2372 466 to 1       466/466
(100 %)
7 diff
(98.5 %id)
BF590612 colon, colon tumor, RER+ HS1BP3.a 1908 to 2371 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
AI480226 anaplastic oligodendroglioma, brain HS1BP3.a 1910 to 2361 452 to 1       452/452
(100 %)
8 diff
(98.3 %id)
AI400122 pooled HS1BP3.a 1911 to 2374 466 to 4       463/466
(99 %)
0 diff
(100 %id)
AI023400 liver and spleen HS1BP3.a 1929 to 2372 455 to 12   AAA   444/444
(100 %)
3 diff
(99.4 %id)
BQ286005 Pancreas, Purified pancreatic islet HS1BP3.a 1929 to 2371 443 to 1       443/443
(100 %)
2 diff
(99.6 %id)
N62141 multiple sclerosis lesions HS1BP3.a 1939 to 2392 454 to 1       454/458
(99 %)
12 diff
(97.4 %id)
AA918824 Kidney HS1BP3.a 1945 to 2373 427 to 1       427/427
(100 %)
5 diff
(98.9 %id)
AI333295 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus HS1BP3.a 1946 to 2374 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
AW129082 brain, tumor, 5 pooled (see description) HS1BP3.a 1952 to 2374 425 to 3       423/425
(99 %)
0 diff
(100 %id)
AI812084 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus HS1BP3.a 1956 to 2374 424 to 6       419/424
(98 %)
0 diff
(100 %id)
DB507083 testis HS1BP3.a 1974 to 2372 1 to 404     Submitted on the opposite strand 404/405
(99 %)
33 diff
(91.9 %id)
AW073365 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma HS1BP3.a 1975 to 2372 412 to 15   AAA   398/398
(100 %)
3 diff
(99.3 %id)
N22970 melanocyte HS1BP3.a 1980 to 2372 395 to 1       395/395
(100 %)
15 diff
(96.3 %id)
AI129956 uterus HS1BP3.a 1981 to 2374 399 to 6       394/399
(98 %)
0 diff
(100 %id)
R93246 liver and spleen HS1BP3.a 1988 to 2361 381 to 1       381/384
(99 %)
14 diff
(96.4 %id)
AW264853 lung, two pooled squamous cell carcinomas HS1BP3.a 1992 to 2374 385 to 3       383/385
(99 %)
0 diff
(100 %id)
AA678415   HS1BP3.a 2000 to 2372 372 to 1       372/372
(100 %)
3 diff
(99.2 %id)
BU958221 mixed (pool of 40 RNAs) HS1BP3.a 2019 to 2372 1 to 354   AAA   354/354
(100 %)
3 diff
(99.2 %id)
AW090142 brain, tumor, 5 pooled (see description) HS1BP3.a 2044 to 2378 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
AA923661 adenocarcinoma, colon HS1BP3.a 2045 to 2372 327 to 1       327/327
(100 %)
5 diff
(98.5 %id)
AA506207 Prostate HS1BP3.a 2052 to 2374 328 to 6       323/335
(96 %)
0 diff
(100 %id)
AA506216 Prostate HS1BP3.a 2052 to 2374 328 to 6       323/335
(96 %)
0 diff
(100 %id)
AW188582 colon, moderately differentiated adenocarcinoma HS1BP3.a 2086 to 2374 288 to 1       288/288
(100 %)
4 diff
(98.7 %id)
AI915717 ovary, tumor, 5 pooled (see description) HS1BP3.a 2093 to 2375 284 to 1       284/284
(100 %)
2 diff
(99.3 %id)
AA507119 Prostate HS1BP3.a 2166 to 2374 214 to 6       209/214
(97 %)
0 diff
(100 %id)
CN413937 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells HS1BP3.a 2276 to 2945 1 to 676   tiling clone,   676/676
(100 %)
10 diff
(98.6 %id)
BX386099 Placenta Cot 25-normalized HS1BP3.b 1 to 841 1 to 842 E140X D141G A142C E143* tiling clone,   842/842
(100 %)
3 diff
(99.7 %id)
BU500865 eye, normal pigmented retinal epithelium HS1BP3.b 160 to 759 1 to 608   tiling clone,   608/1130
(53 %)
20 diff
(98.3 %id)
BQ300261 bladder_tumor HS1BP3.b 292 to 739 34 to 484       451/484
(93 %)
16 diff
(96.7 %id)
BM799023 Ascites, stomach HS1BP3.b 341 to 739 1 to 399   tiling clone,   399/399
(100 %)
3 diff
(99.3 %id)
BX345340 Placenta Cot 25-normalized HS1BP3.c 1 to 1031 1 to 1041 exact tiling clone,   1041/1127
(92 %)
37 diff
(96.8 %id)
BC027947 Lung, Spleen, fetal, pooled HS1BP3.c 4 to 2361 1 to 2356 exact tiling clone, available from MGC, AAA   2356/2356
(100 %)
6 diff
(99.8 %id)
BI767288 pooled lung and spleen HS1BP3.c 4 to 799 1 to 795 A142L A143Q L145S T146P S147A ... available from MGC,   795/796
(99 %)
8 diff
(99.0 %id)
TI_57181403   HS1BP3.c 4 to 799 66 to 860 A142L A143Q L145S T146P S147A ...     795/861
(92 %)
13 diff
(98.5 %id)
BM473190 duodenal adenocarcinoma, cell line, small intestine HS1BP3.c 13 to 700 1 to 692 L209V C212L C213L available from MGC,   692/1085
(63 %)
8 diff
(99.3 %id)
TI_1948090000   HS1BP3.c 26 to 463 131 to 568   fully sequenced,   438/466
(93 %)
6 diff
(98.8 %id)
TI_1948090121   HS1BP3.c 26 to 346 128 to 448   fully sequenced,   321/348
(92 %)
6 diff
(98.3 %id)
TI_1948090383   HS1BP3.c 26 to 346 126 to 446   fully sequenced,   321/348
(92 %)
6 diff
(98.3 %id)
TI_1948090258   HS1BP3.c 170 to 667 621 to 124       498/525
(94 %)
0 diff
(100 %id)
TI_1948090122   HS1BP3.c 316 to 667 478 to 127   fully sequenced,   352/478
(73 %)
0 diff
(100 %id)
TI_1948090384   HS1BP3.c 316 to 667 478 to 127   fully sequenced,   352/478
(73 %)
0 diff
(100 %id)
TI_1948090001   HS1BP3.c 402 to 667 391 to 126   fully sequenced,   266/293
(90 %)
0 diff
(100 %id)
BF879858 lung_tumor HS1BP3.c 1352 to 1717 104 to 469   tiling clone,   366/469
(78 %)
6 diff
(98.8 %id)
BF197459 Kidney HS1BP3.c 1961 to 2434 472 to 1   tiling clone,   472/472
(100 %)
2 diff
(99.6 %id)
AW452124   HS1BP3.c 2063 to 2422 378 to 18   AAA   361/361
(100 %)
1 diff
(99.8 %id)
BF590885 colon, colon tumor, RER+ HS1BP3.c 2070 to 2423 357 to 3       355/357
(99 %)
0 diff
(100 %id)
AW237842 Kidney HS1BP3.c 2082 to 2434 353 to 1       353/353
(100 %)
4 diff
(98.9 %id)
BF197478 Kidney HS1BP3.c 2227 to 2428 208 to 6       203/208
(97 %)
0 diff
(100 %id)
BC038847 Skin, melanotic melanoma. HS1BP3.d 1 to 1365 12 to 1376 exact tiling clone, available from MGC, AAA   1365/1365
(100 %)
0 diff
(100 %id)
BQ224426 melanotic melanoma, skin HS1BP3.d 3 to 856 1 to 864 exact available from MGC,   864/871
(99 %)
10 diff
(98.9 %id)
TI_227714414   HS1BP3.d 543 to 1372 924 to 96   AAA   829/972
(85 %)
12 diff
(98.8 %id)
CD365184 Alveolar Macrophage, lung HS1BP3.d 693 to 1372 697 to 19   AAA   679/679
(100 %)
2 diff
(99.8 %id)
BM041310 Kidney, Wilms' tumor, cell line HS1BP3.d 732 to 1294 578 to 3       576/780
(73 %)
0 diff
(100 %id)
AI476172 follicular lymphoma, lymph node HS1BP3.d 896 to 1365 470 to 1       470/470
(100 %)
0 diff
(100 %id)
CR977691 T-Lymphocytes HS1BP3.e 1 to 710 4 to 714 exact tiling clone,   714/714
(100 %)
2 diff
(99.8 %id)
AA883889 pooled HS1BP3.e 200 to 709 517 to 9       509/517
(98 %)
5 diff
(99.1 %id)
AW295360   HS1BP3.e 470 to 716 264 to 18   AAA   247/267
(92 %)
2 diff
(99.3 %id)
BG150469 pooled germ cell tumors HS1BP3.e 492 to 716 225 to 1   tiling clone,   225/225
(100 %)
1 diff
(99.6 %id)
AI655332 pooled germ cell tumors HS1BP3.e 493 to 716 223 to 1       223/223
(100 %)
4 diff
(98.3 %id)
AK123411 hippocampus HS1BP3.f 1 to 2005 7 to 2011 V50M tiling clone, available from FLJ,   2011/2011
(100 %)
11 diff
(99.5 %id)
DA290552 hippocampus HS1BP3.f 1 to 614 8 to 621 V50M capped   619/620
(99 %)
7 diff
(98.9 %id)
BM804878 ovary (pool of 3) HS1BP3.f 14 to 825 1 to 817       817/973
(83 %)
11 diff
(98.9 %id)
AA889692   HS1BP3.f 144 to 609 469 to 6       464/469
(98 %)
1 diff
(99.8 %id)
CN479073 Human Lung Epithelial cells, lung HS1BP3.f 1425 to 2005 599 to 19   AAA   581/581
(100 %)
6 diff
(99.0 %id)
BF963017 nervous_normal HS1BP3.f 1440 to 1561 129 to 9       121/129
(93 %)
0 diff
(100 %id)
DB307629 hippocampus HS1BP3.f 1505 to 2005 503 to 1       503/503
(100 %)
6 diff
(98.9 %id)
BF589826 sciatic nerve HS1BP3.f 1546 to 2006 465 to 5       461/465
(99 %)
0 diff
(100 %id)
AW297800   HS1BP3.f 1562 to 2005 461 to 18   AAA   444/444
(100 %)
35 diff
(92.2 %id)
AA836575 germinal center B cell HS1BP3.f 1574 to 2006 439 to 10   tiling clone,   430/439
(97 %)
0 diff
(100 %id)
AA931785 carcinoid, lung HS1BP3.f 1596 to 2001 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AA837363 germinal center B cell HS1BP3.f 1627 to 2006 389 to 10       380/389
(97 %)
0 diff
(100 %id)
BF959573 nervous_normal HS1BP3.f 1639 to 1944 307 to 2       306/307
(99 %)
0 diff
(100 %id)
BF090096 nervous_normal HS1BP3.f 1744 to 1946 1 to 202       202/202
(100 %)
3 diff
(98.6 %id)
AA325895 brain, cerebellum HS1BP3.g 1 to 421 425 to 6 V12M D20X G66A K67N Q68K ... tiling clone, Submitted on the opposite strand 420/427
(98 %)
3 diff
(99.3 %id)
BX360116 Placenta Cot 25-normalized HS1BP3.h-u 269 to 724 459 to 1 N2X K3T C4N T5X C6X ... tiling clone,   459/459
(100 %)
24 diff
(94.8 %id)
AK024311 ovary, tumor tissue Gene HS1BP3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BF959283 nervous_normal Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
CN310012 embryonic stem cells, cell lines H1, H7, andH9 Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
BX351983 Placenta Cot 25-normalized Gene HS1BP3, variant not shown              
N68944 lung Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
AA877826 colon, colon tumor RER+ Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
BG390708 embryonal carcinoma, cell line, testis Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
BC057389 Duodenum, adenocarcinoma Gene HS1BP3, variant not shown       available from MGC, AAA This clone was ignored    
AU155178 ovary, tumor tissue Gene HS1BP3, variant not shown         Suspected internal deletion, this clone was ignored    
AU134068 ovary, tumor tissue Gene HS1BP3, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI